Amcinonide
Drug - Amcinonide
The trade name of the product as shown on the labeling.
Dosage -
OINTMENT; TOPICAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Amcinonide
Multiple ingredients are in alphabetical order.
Strength -
0.1%
The potency of the active ingredient(s), Amcinonide. May repeat for multiple part products.
Applicant -
ALTANA
The firm name holding legal responsibility for Amcinonide. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
076096
The FDA assigned number to Amcinonide. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Amcinonide. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Nov 19, 2002
The date Amcinonide was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Amcinonide. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Amcinonide is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Altana Inc
The full name of the firm holding legal responsibility for the new application of Amcinonide.
Amcinonide
|
